Overview
Dr. James Xu received a bachelor of science in chemical engineering with a minor in mathematics from Brigham Young University and his medical degree from University of Minnesota. He completed his internal medicine residency at the Yale-New Haven Hospital of Yale University in New Haven, CT, and his hematology and medical oncology fellowship at the New York-Presbyterian Hospital of Columbia University in New York City. Because of his unique background in engineering and medicine, Dr. Xu was the recipient of the American Society of Clinical Oncology-Conquer Cancer Foundation Young Investigator Award in 2011 and Merit Award in 2012. Dr. Xu is a strong advocate of precision medicine and he is the first person to have proposed and preliminarily confirmed the feasibility of using deep sequencing technology to detect genetic mutation in rare cell samples such as circulating tumor cells from cancer patients’ peripheral blood. He has published in peer-reviewed journals in lung, breast, and pancreatic cancers.
Dr. Xu is rated as an Experienced provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Protein S Deficiency, and Congenital Antithrombin 3 Deficiency.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Suite 501, Rockville, MD 20852
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Maryland Oncology Hematology PA
Kashif Ali is a Hematologist Oncology specialist and a Hematologist in Laurel, Maryland. Dr. Ali is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Iron Deficiency Anemia, Agranulocytosis, Chronic Familial Neutropenia, and Childhood Iron Deficiency Anemia. Dr. Ali is currently accepting new patients.
Maryland Oncology Hematology PA
Frederick Min is a Hematologist Oncology specialist and an Oncologist in Laurel, Maryland. Dr. Min is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Chronic Familial Neutropenia, and Agranulocytosis. Dr. Min is currently accepting new patients.
Maryland Oncology Hematology
As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Pulmonary EmbolismDr. Xu isDistinguished. Learn about Pulmonary Embolism.
- Advanced
- AnemiaDr. Xu isAdvanced. Learn about Anemia.
- Childhood Iron Deficiency Anemia
- Congenital Antithrombin 3 Deficiency
- Deep Vein ThrombosisDr. Xu isAdvanced. Learn about Deep Vein Thrombosis.
- Hereditary Resistance to Anti-Vitamin K
- Iron Deficiency AnemiaDr. Xu isAdvanced. Learn about Iron Deficiency Anemia.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Xu isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Xu isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Xu isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Xu isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Alpha ThalassemiaDr. Xu isExperienced. Learn about Alpha Thalassemia.